A retrospective study of high mobility group protein I(Y) as progression marker for prostate cancer determined by in situ hybridization

This publication has 33 references indexed in Scilit:

• The high mobility group protein HMG I(Y) can stimulate or inhibit DNA binding of distinct transcription factor ATF-2 isoforms.
  Proceedings of the National Academy of Sciences, 1994
• Prognostic significance of cell proliferation in mucoepidermoid carcinomas of the salivary gland: Clinicopathological study using MIB 1 antibody in paraffin sections
  Human Pathology, 1994
• Cooperativity between two NF-kappa B complexes, mediated by high-mobility-group protein I(Y), is essential for cytokine-induced expression of the E-selectin promoter.
  Molecular and Cellular Biology, 1994
• Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer.
  1994
• Cancer statistics, 1994
  CA: A Cancer Journal for Clinicians, 1994
• Increased expression of high mobility group protein I(Y) in high grade prostatic cancer determined by in situ hybridization.
  1993
• SAR-dependent mobilization of histone H1 by HMG-I/Y in vitro: HMG-I/Y is enriched in H1-depleted chromatin.
  1993
• Elevated high mobility group-I(Y) gene expression is associated with progressive transformation of mouse mammary epithelial cells.
  1993
• Multiple closely-linked NFAT/octamer and HMG I(Y) binding sites are part of the interleukin-4 promoter
  Nucleic Acids Research, 1993
• Acetylation of chromosome squashes of Drosophila melanogaster decreases the background in autoradiographs from hybridization with [125I]-labeled RNA.
  Journal of Histochemistry & Cytochemistry, 1978